Opsumit 10MG-QTY 2 @ 6,270.03
Ended Awarded Last action
- Contract number
- 15B50526F00000010
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,540
Award facts
- Contract value 100% obligated
- $12,540.06 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $12,540 | |
| Original award | $0 |
About this award
Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at $12.5M by the Federal Medical Center Carswell, a civilian facility under the Department of Veterans Affairs, for the procurement of Opsumit 10mg (quantity 2 @ $6,270.03 each). This firm fixed-price delivery order, awarded on October 31, 2025, with an ultimate completion date of October 31, 2025, carries no small business set-aside designation. The contract will be performed in Titusville, Hopewell Township, New Jersey, where Actelion maintains its headquarters operations.
This delivery order is issued under Actelion's Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, a multiple-award indefinite delivery vehicle valued at approximately $219.1M and running through July 2029. Opsumit (ambrisentan) is a critical pharmaceutical used in the treatment of pulmonary arterial hypertension, a rare disease affecting federal beneficiaries including veterans and incarcerated individuals. As a specialized pharmaceutical manufacturer with extensive experience supplying rare disease treatments to federal medical centers and correctional facilities, Actelion serves as the primary supplier of this essential medication through pre-negotiated pricing mechanisms that streamline procurement for federal healthcare institutions.
Quick answers
Who was awarded contract 15B50526F00000010?
15B50526F00000010 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Medical Center Carswell (Correctional Facilities) on October 31, 2025.
How much is contract 15B50526F00000010 worth?
The government has obligated $12,540 on 15B50526F00000010.
Is contract 15B50526F00000010 an order under another contract?
Yes. 15B50526F00000010 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000010 competed?
The extent of competition for 15B50526F00000010 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award